Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

Abstract

Background Diabetic patients on haemodialysis have a higher risk of mortality than non-diabetic patients. The aim of this COSMOS analysis was to assess whether bone and mineral laboratory values (calcium, phosphorus, and PTH) contribute to such risk. Methods COSMOS is a multicentre, open-cohort, 3-year prospective study, which includes 6797 patients from 227 randomly selected dialysis centres from 20 European countries. The association between mortality and calcium, phosphate or PTH was assessed using Cox proportional hazard regression models using both penalized splines smoothing and categorization according to KDIGO guidelines. The effect modification of the association between the relative risk of mortality and serum calcium, phosphate or PTH by diabetes was assessed. Results There was a statistically significant effect modification of the association between the relative risk of mortality and serum PTH by diabetes (p = 0.011). The slope of the curve of the association between increasing values of PTH and relative risk of mortality was steeper for diabetic compared with non-diabetic patients, mainly for high levels of PTH. In addition, high serum PTH (> 9 times the normal values) was significantly associated with a higher relative risk of mortality in diabetic patients but not in non-diabetic patients (1.53[95%CI:1.07-2.19] and 1.17[95%CI:0.91-1.52]). No significant effect modification of the association between the relative risk of mortality and serum calcium or phosphate by diabetes was found (p = 0.2 and p = 0.059, respectively). Conclusion The results show a different association of PTH with the relative risk of mortality in diabetic and non-diabetic patients. These findings could have relevant implications for the diagnosis and treatment of CKD-MBD.

Association of Hyperparathyroidism with Depression and Anxiety Among Chronic Hemodialysis Patients in the Al Baha Region, Kingdom of Saudi Arabia

“…Diabetes and hypertension were the most common primary cause of end-stage renal disease among participants in this study. Patients diagnosed with diabetes mellitus are prone to major depression, and the disease is associated with elevated PTH and linked to bone disease [ 29 , 30 ]. Further studies are required to understand this relation.…”

Non-nitrogen-containing bisphosphonates and nitrogen-containing bisphosphonates for the treatment of atherosclerosis and vascular calcification: A meta-analysis

“…Serum calcium, phosphorus, and PTH levels are associated with bone metabolism and VC, especially in patients with renal insufficiency. [ 2 , 35 , 36 ] One previous study showed that BPs are inhibitors of osteoclastic bone resorption and decrease serum calcium and phosphorus levels and increase PTH levels in a dose-dependent fashion. [ 37 ] However, our meta-analysis showed that neither non-N-BPs nor N-BPs affected serum calcium, phosphorus or PTH levels in patients who underwent hemodialysis or kidney transplantation.…”